Hot flushes in women with breast cancer: State of the art and future perspectives

Maddalena Barba, Laura Pizzuti, Domenico Sergi, Marcello Maugeri-Saccà, Cristina Vincenzoni, Francesca Conti, Federica Tomao, Enrico Vizza, Luigi Di Lauro, Franco Di Filippo, Silvia Carpano, Luciano Mariani, Patrizia Vici

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Although not life-threatening, vasomotor symptoms might have a detrimental effect on quality of life and represent a major determinant of poor therapeutic compliance in breast cancer patients. Limitations of hormonal therapies have fostered the use of non-estrogenic pharmacological agents, which mainly include centrally acting compounds, antidepressant drugs, serotonin-norepinephrine reuptake inhibitors and serotonin reuptake inhibitors. Integrating therapeutic tools have recently come from a wide range of heterogeneous approaches varying from phytoestrogens use to ganglion block. We herein critically review the most updated evidence on the available treatment options for management of vasomotor symptoms. The need for a patient-oriented approach following systematic evaluation of the presence and degree of vasomotor disturbances is also discussed and future perspectives in therapeutics are summarized.

Original languageEnglish
Pages (from-to)185-198
Number of pages14
JournalExpert Review of Anticancer Therapy
Volume14
Issue number2
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Breast Neoplasms
Therapeutics
Phytoestrogens
Serotonin Uptake Inhibitors
Ganglia
Antidepressive Agents
Quality of Life
Pharmacology

Keywords

  • breast cancer therapy
  • complementary and alternative medicine
  • hot flushes
  • non-hormonal therapy
  • vasomotor symptoms

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Hot flushes in women with breast cancer : State of the art and future perspectives. / Barba, Maddalena; Pizzuti, Laura; Sergi, Domenico; Maugeri-Saccà, Marcello; Vincenzoni, Cristina; Conti, Francesca; Tomao, Federica; Vizza, Enrico; Di Lauro, Luigi; Di Filippo, Franco; Carpano, Silvia; Mariani, Luciano; Vici, Patrizia.

In: Expert Review of Anticancer Therapy, Vol. 14, No. 2, 02.2014, p. 185-198.

Research output: Contribution to journalArticle

Barba, M, Pizzuti, L, Sergi, D, Maugeri-Saccà, M, Vincenzoni, C, Conti, F, Tomao, F, Vizza, E, Di Lauro, L, Di Filippo, F, Carpano, S, Mariani, L & Vici, P 2014, 'Hot flushes in women with breast cancer: State of the art and future perspectives', Expert Review of Anticancer Therapy, vol. 14, no. 2, pp. 185-198. https://doi.org/10.1586/14737140.2013.856271
Barba, Maddalena ; Pizzuti, Laura ; Sergi, Domenico ; Maugeri-Saccà, Marcello ; Vincenzoni, Cristina ; Conti, Francesca ; Tomao, Federica ; Vizza, Enrico ; Di Lauro, Luigi ; Di Filippo, Franco ; Carpano, Silvia ; Mariani, Luciano ; Vici, Patrizia. / Hot flushes in women with breast cancer : State of the art and future perspectives. In: Expert Review of Anticancer Therapy. 2014 ; Vol. 14, No. 2. pp. 185-198.
@article{fd6ac2d8d614449da3773c604972dd29,
title = "Hot flushes in women with breast cancer: State of the art and future perspectives",
abstract = "Although not life-threatening, vasomotor symptoms might have a detrimental effect on quality of life and represent a major determinant of poor therapeutic compliance in breast cancer patients. Limitations of hormonal therapies have fostered the use of non-estrogenic pharmacological agents, which mainly include centrally acting compounds, antidepressant drugs, serotonin-norepinephrine reuptake inhibitors and serotonin reuptake inhibitors. Integrating therapeutic tools have recently come from a wide range of heterogeneous approaches varying from phytoestrogens use to ganglion block. We herein critically review the most updated evidence on the available treatment options for management of vasomotor symptoms. The need for a patient-oriented approach following systematic evaluation of the presence and degree of vasomotor disturbances is also discussed and future perspectives in therapeutics are summarized.",
keywords = "breast cancer therapy, complementary and alternative medicine, hot flushes, non-hormonal therapy, vasomotor symptoms",
author = "Maddalena Barba and Laura Pizzuti and Domenico Sergi and Marcello Maugeri-Sacc{\`a} and Cristina Vincenzoni and Francesca Conti and Federica Tomao and Enrico Vizza and {Di Lauro}, Luigi and {Di Filippo}, Franco and Silvia Carpano and Luciano Mariani and Patrizia Vici",
year = "2014",
month = "2",
doi = "10.1586/14737140.2013.856271",
language = "English",
volume = "14",
pages = "185--198",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Hot flushes in women with breast cancer

T2 - State of the art and future perspectives

AU - Barba, Maddalena

AU - Pizzuti, Laura

AU - Sergi, Domenico

AU - Maugeri-Saccà, Marcello

AU - Vincenzoni, Cristina

AU - Conti, Francesca

AU - Tomao, Federica

AU - Vizza, Enrico

AU - Di Lauro, Luigi

AU - Di Filippo, Franco

AU - Carpano, Silvia

AU - Mariani, Luciano

AU - Vici, Patrizia

PY - 2014/2

Y1 - 2014/2

N2 - Although not life-threatening, vasomotor symptoms might have a detrimental effect on quality of life and represent a major determinant of poor therapeutic compliance in breast cancer patients. Limitations of hormonal therapies have fostered the use of non-estrogenic pharmacological agents, which mainly include centrally acting compounds, antidepressant drugs, serotonin-norepinephrine reuptake inhibitors and serotonin reuptake inhibitors. Integrating therapeutic tools have recently come from a wide range of heterogeneous approaches varying from phytoestrogens use to ganglion block. We herein critically review the most updated evidence on the available treatment options for management of vasomotor symptoms. The need for a patient-oriented approach following systematic evaluation of the presence and degree of vasomotor disturbances is also discussed and future perspectives in therapeutics are summarized.

AB - Although not life-threatening, vasomotor symptoms might have a detrimental effect on quality of life and represent a major determinant of poor therapeutic compliance in breast cancer patients. Limitations of hormonal therapies have fostered the use of non-estrogenic pharmacological agents, which mainly include centrally acting compounds, antidepressant drugs, serotonin-norepinephrine reuptake inhibitors and serotonin reuptake inhibitors. Integrating therapeutic tools have recently come from a wide range of heterogeneous approaches varying from phytoestrogens use to ganglion block. We herein critically review the most updated evidence on the available treatment options for management of vasomotor symptoms. The need for a patient-oriented approach following systematic evaluation of the presence and degree of vasomotor disturbances is also discussed and future perspectives in therapeutics are summarized.

KW - breast cancer therapy

KW - complementary and alternative medicine

KW - hot flushes

KW - non-hormonal therapy

KW - vasomotor symptoms

UR - http://www.scopus.com/inward/record.url?scp=84893239585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893239585&partnerID=8YFLogxK

U2 - 10.1586/14737140.2013.856271

DO - 10.1586/14737140.2013.856271

M3 - Article

C2 - 24313623

AN - SCOPUS:84893239585

VL - 14

SP - 185

EP - 198

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 2

ER -